Co-Diagnostics (NASDAQ:CODX) Inc said it has completed the acquisition of Idaho Molecular Inc and Advanced Conception Inc to provide the company with all existing and future assets and intellectual property related to its upcoming at-home/point-of-care diagnostic device. The transaction was settled for 4.72 million shares of Co-Diagnostics (NASDAQ:CODX) stock, and additional common warrants totaling 465,000. The Salt Lake City, Utah-based company said that the acquisition is expected to streamline the commercialization of the Eikon platform and YourTest PCR device as it nears completion. The device has been designed with highly specialized optics to accommodate multiplexed assays as the company expands its future suite of Eikon products to include additional respiratory and other infectious diseases utilizing its patented CoPrimer technology, the company said.
BioPorto (NASDAQ COPENHAG:BIOPOR) A/S said it has exercised its current authorization by issuing 12.6 million warrants to key employees and executive management of the company. Each warrant grants the holder the right to subscribe for one share in BioPorto (NASDAQ COPENHAG:BIOPOR). The exercise price is DKK 2.47 per share. The warrants generally vest over a four-year period. The warrants include conditions on claw-back in case of events like erroneous financial information and provisions on accelerated vesting in case of for example a takeover bid and/or business combinations, and with regard to a total of 1,700,000 warrants, upon U.S Food & Drug Administration approval of The NGAL Test for pediatric use.
Organic Garage (TSX-V:OG) Ltd released its 3Q 2021 results that showed its gross profit margins increased despite inflationary pressures and supply chain issues that faced many retailers this year. The grocery store chain posted revenue of $5.9 million during the three-month period to end October 31, 2021, compared to $6.9 million in the same year-ago quarter as the impact of pandemic-related overstocking subsided, according to Organic Garage (TSX-V:OG). Gross profit margin, however, increased from 30.4% to 31.3%.
Jack Nathan Medical Corp (Jack Nathan Health) revealed a 143% revenue increase in its fiscal 3Q results as its clinic operations ramped up. The healthcare company reported total 3Q revenue of C$2.4 million, a jump from the nearly $1 million it reported in the comparable three-month period ended October 31 last year. In a statement accompanying the results, Jack Nathan attributed the revenue increase to “high clinic operations revenue from acquisitions and organic growth in Canada, including Rehab and MedSpa services, in Canada, and new medical clinics and services in Mexico.”
Empower Clinics Inc announced that its subsidiary The Medi-Collective (TMC) has opened a new clinic in London, Ontario. The clinic is accepting new patients from December 31, 2021, the company said. The company said that the fully renovated 3,400 square foot location will offer family medicine, teledermatology, and paramedical services such as chiropractor, physiotherapy, registered massage therapy, and custom bracing orthotics. There are currently five family doctors on staff with plans to hire general practice and specialist physicians to accommodate additional services in the coming months. Support medical staff are equipped through Empower's partnership with MedX Health Corporation to facilitate teledermatology appointments. "Our team has made immense progress in growing our footprint this year despite the operational and logistical challenges brought on by the pandemic and supply chain crisis," said Steven McAuley, CEO of Empower, in a statement.
Helix BioPharma Corp called 2021 a "productive year" in a year-end corporate update to shareholders. The Richmond Hill, Ontario-based firm is a clinical-stage biopharmaceutical company developing unique therapies in the field of immune-oncology for the prevention and treatment of cancer based on its proprietary technological platform DOS47. During the second half of 2021, the company initiated efforts to validate its lead clinical program with external stakeholders to bring in an outside perspective to the company's strategy and future, the company said. "Our clinical program remains our highest priority to ensure we deliver on a substantial data package that would ultimately benefit patients and stakeholders alike. We await the final trial reports of Phase I and II studies in lung cancer in 2022,” said Slawomir Majewski, interim CEO.
BioPorto (NASDAQ COPENHAG:BIOPOR) A/S has said it is supporting Rigshospitalet (RH (NYSE:RH)), Copenhagen, with quantitative thrombomodulin tests based on its generic Rapid Assay Device (gRAD) technology. RH (NYSE:RH) is investigating the potential for thrombomodulin blood levels to be used as a marker in patients with sepsis to indicate who could benefit from treatment with the drug prostacyclin. It is currently summarizing findings from its feasibility study and plans to publish the results after completing its assessment. BioPorto (NASDAQ COPENHAG:BIOPOR) said it is also using the gRAD platform in a feasibility study to detect SARS-CoV-2, the virus that causes coronavirus (COVID-19).
Adyton Resources (TSX-V:ADY, OTCQB:ADYRF) Corporation has announced the appointment of David Irvine to its board as an independent non-executive director with effect from December 31, 2021, subject to the approval of the TSX Venture Exchange, part of a board restructuring. The company also announced the appointment of existing directors Sinton Spence and Tim Crossley as chairman of the board and Interim CEO, respectively. The new board consisting of Spence and Crossley and new appointee Irvine, will govern the company on an interim basis as it restructures its board and executive team.
Victory Square Technologies Inc (CSE:VST, OTCQX:VSQTF) said it has completed the second tranche of its special dividend of common shares in the capital of its portfolio company Immersive to shareholders. This second dividend represented approximately 4,500,000 shares in Immersive, which when added to the 4,500,000 Immersive Shares previously dividended by Victory Square to its shareholders earlier this year, represents a total of 9,000,000 Immersive shares dividended to Victory Square shareholders. The second tranche dividend was completed on December 30, 2021. Prior to completion of the second dividend, Victory Square held 57,588,520 Immersive shares representing 75.72% of the shares issued and outstanding and following the second dividend, Victory Square held 53,088,520 Immersive shares representing 69.81% of the issued and outstanding, in each case on a non-diluted basis.
Eric Sprott has announced that 2176423 Ontario Ltd, a corporation he beneficially owns, has exercised 1,130,000 common share purchase warrants of Benchmark Metals Inc at $0.40 per share for an aggregate consideration of $452,000. The exercise of warrants, combined with prior corporate treasury issuances of shares, resulted in a decrease in holdings of approximately 3.1% of Benchmark outstanding Shares on a partially diluted basis since the date of the last early warning report. Prior to the exercise of these warrants, Sprott beneficially owned and controlled 24,952,309 Benchmark shares and 4,976,154 warrants representing approximately 12.4% of the outstanding shares on a non-diluted basis and approximately 14.6% on a partially diluted basis assuming the exercise of all such warrants. Sprott now beneficially owns and controls 26,082,309 Benchmark shares and 3,846,154 warrants representing approximately 12.9% of the outstanding shares on a non-diluted basis and approximately 14.6% on a partially diluted basis assuming the exercise of such warrants. The exercise of warrants resulted in a partially diluted ownership change of greater than 2% and, therefore, the filing of an update to the early warning report. The securities noted above are held for investment purposes. Sprott has a long-term view of the investment and may acquire additional securities including on the open market or through private acquisitions or sell the securities including on the open market or through private dispositions in the future depending on market conditions, reformulation of plans and/or other relevant factors.
Plurilock Security Inc said it has entered into an online marketing agreement with AGORA Internet Relations Corp. Under the terms and conditions of the agreement, AGORA will assist the company with its launch of a 12-month online marketing campaign. AGORA will assist the company with ad placements and other branding initiatives which will be posted on AGOROCOM and distributed on YouTube, various social media platforms, and all podcast platforms. In connection with the services provided under the agreement, the company will pay AGORA aggregate consideration of $100,000 plus applicable taxes, which shall be paid via the issuance of common shares in the capital of the company. The payment shares will be issued in five installments throughout the term of the AGORA Agreement, which will commence on January 1, 2022, and ends on December 30, 2022, subject to the approval of the TSX Venture Exchange
NorthWest Copper (TSX-V:NWST) Corp announced that it has granted 3,575,000 stock options to directors, certain employees and consultants, and 1,175,000 Restricted Share Units (RSUs) to certain employees and consultants under its stock option and RSU plans. The stock options have an exercise price of $0.80 and have a range of vesting periods over three years and expire after five years. The RSUs are payable in common shares of the company on exercise, have a range of vesting periods over three years and must be redeemed within 30 days of December 29, 2024, or they expire.